The recent rallies of CRISPR Therapeutics and Moderna are captivating yet divergent stories in biotech's evolving landscape. CRISPR's shift to profitability, thanks to its gene-editing therapy Casgevy, contrasts sharply with...
Elon Musk's venture into potential political territory has sent ripples through prediction markets, with odds of forming an "America Party" dropping from 76% to 62%. This intriguing shift has investors...
Explore how the intriguing "two-party doom loop" creates a quantifiable uncertainty premium gripping US asset prices. Delve into why political polarisation, described as legislative paralysis, impacts corporate investment strategies and...
Bio-Rad Laboratories, a key player in the life sciences and diagnostics arena, offers a promising investment opportunity with a 12-month price target of $350, indicating a potential 39.2% upside from...
Waymo's venture into New York City isn't merely an exploration; it's a strategic conquest of the ultimate urban labyrinth. As the competition thins, particularly with Cruise's setbacks, Waymo finds itself...
The proposed 10% US tariff on European Union goods may seem a step towards peace, but lurking "caveats" could derail the tranquillity. Industries like European automotive could bear the brunt,...
The US Dollar encountered its steepest first-half decline since 1973, fuelled by expectations of a Federal Reserve pivot and buoyant global economic growth. However, the dollar roared back in the...
A spate of insider share purchases at Immuneering has sparked intrigue, suggesting internal confidence amidst its precarious financial backdrop. With its lead drug, IMM-1-104, potentially stirring hope for RAS-mutant cancer...
Rocket Lab's meteoric rise is fuelled by tangible accomplishments, not mere market speculation. With its robust portfolio of successful launches, a diversified revenue stream, and strategic vertical integration, the company...
The proposed dynamic tariffs, including a universal 10% baseline and up to 60% on Chinese goods, are poised to act as a hefty tax on domestic consumption. With potential GDP...
